No single AI fits every medical writing task. Compare regulatory authoring platforms, evaluate key criteria, and learn how to govern AI in medical writing.
Explore our vision for AuroraPrime's next generation: a pharma AI authoring platform shaped around connected knowledge, expert judgment, and collaboration.
Preview RMA 2026.10.31, the pharma AI authoring platform update for Clinical Summaries, TFLs, and CMC drafts. Explore what is coming for your writing team.
AI protocol writing starts before drafting. Learn how governed protocol knowledge bases turn prior studies, synopses, templates, and source metadata into usable authoring context.
A DSUR (Development Safety Update Report) is the annual safety report for a drug in clinical development, due within 60 calendar days of data lock (ICH E2F).
What is a regulatory submission? Learn the types of FDA submissions, how dossiers are structured under the CTD & how submissions are filed & validated.
An eCTD has five modules: regional information, summaries, quality, nonclinical reports and clinical reports. See what each module contains and who writes it.
Regulatory documents are also reader experiences. Learn how AI Regulatory and Medical Authoring can support clarity, consistency, and evidence-aware narratives.
Plain language turns an Informed Consent Form into a better participant experience. See how governed AI authoring can support clearer clinical communication.
AI CMC authoring software should organize relationships before it drafts. Learn why information architecture matters to better CMC authoring workflows.
A pharma AI writing platform pilot needs exit criteria for workflow, people, evidence, exceptions, and repeatability. Use this pilot-to-practice scorecard.